Tumor and immune features associated with disease-free survival with adjuvant nivolumab in the phase III CheckMate 274 trial Meeting Abstract
| Authors: | Necchi, A.; Bajorin, D. F.; Tomita, Y.; Ye, D.; Agerbaek, M.; Enting, D.; Peer, A.; Milowsky, M.; Kobayashi, K.; Grimm, M. O.; Stenner-Liewen, F.; David, J. M.; Li, J.; Chasalow, S. D.; Nasroulah, F.; Apfel, A.; Unsal-Kacmaz, K.; Galsky, M. D. |
| Abstract Title: | Tumor and immune features associated with disease-free survival with adjuvant nivolumab in the phase III CheckMate 274 trial |
| Meeting Title: | ESMO Congress 2022 |
| Journal Title: | Annals of Oncology |
| Volume: | 33 |
| Issue: | Suppl. 7 |
| Meeting Dates: | 2022 Sep 9-13 |
| Meeting Location: | Paris, France |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2022-09-01 |
| Start Page: | S1331 |
| Language: | English |
| ACCESSION: | WOS:000866211602287 |
| DOI: | 10.1016/j.annonc.2022.07.1815 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 1737MO -- Source: Wos |
